Accession Number:



Military Exposure-Related Pleural Mesothelioma: An Innovative Translational Approach to Inform Novel Molecular-Targeted Treatment Development

Descriptive Note:

Technical Report,01 Aug 2019,31 Jul 2020

Corporate Author:

Brigham and Womens Hospital, Inc. Boston United States

Report Date:


Pagination or Media Count:



Malignant pleural mesothelioma MPM is a highly aggressive form of cancer that develops within the pleural lining of the lungs. Asbestos-related malignancies dropped precipitously in militaryveteran populations upon the removal of asbestos from naval ship construction. However, older naval vessels and military facilities still containing asbestos were still in use decades later, resulting in thousands of veterans suffering asbestos exposure. Indeed, it is estimated that military veterans account for one third of all MPM patients. Despite this estimation, there is little data on the phenotype of military exposure and MPM pathogenesis. We recently defined the mutational landscape of MPM and have identified the most commonly mutated genes as BAP1, NF2, TP53, and SETD2, as well as other frequent mutations. We have also classified MPM into 4 distinct molecular clusters that provide new opportunities to identify MPM patients with better prognosis as well as to rationally divide tumors based on distinct molecularbiochemical driving mechanisms.

Subject Categories:

  • Medicine and Medical Research
  • Genetic Engineering and Molecular Biology
  • Biochemistry

Distribution Statement: